About Pediatric Cancer Research Foundation
Fund research to power cures that reduce the percentage of children who perish from cancers until that number reaches zero.
Focus Areas
Pediatric cancer researchTranslational researchWorkforce development in pediatric oncologySurvivorship programsMental health support for survivors and familiesScholarships for survivors
Who They Fund
children and adolescents with cancerfamilies of seriously ill pediatric patientspediatric patients with specific tumor types (brain tumors, sarcomas, leukemias)
Funding Style
translational research funding
About Pediatric Cancer Research Foundation
The Pediatric Cancer Research Foundation has built a recurring pattern around large, project-specific support for pediatric oncology, with a standout $900,000 grant to New York Medical College for the Pediatric Cancer Research Foundation Laboratory at NYMC. Across the recent grants list, its funding reaches laboratory research, translational studies, survivorship support, and care-program work, all tied to childhood cancer. The foundation’s stated aim is to fund research that powers cures and reduces the percentage of children who die from cancer until that number reaches zero. Recent awards show the foundation backing both established centers and targeted projects. Memorial Sloan Kettering received support for curative epigenetic therapies of refractory pediatric sarcomas, while Stanford University was funded for work on small molecules targeting the CRED:CBP interaction in AML. The grants also include pediatric leukemia, brain tumor, and sarcoma projects, along with programs for children and families affected by cancer. Funding sizes cluster around the $50,000 to $75,000 range for many project grants, but the foundation also makes much larger commitments when it funds a named laboratory or longer-term collaboration.
What Pediatric Cancer Research Foundation Funds
A major theme in the foundation’s grantmaking is pediatric cancer biology and therapeutics. It gave $150,000 to Memorial Sloan Kettering for curative epigenetic therapies of refractory pediatric sarcomas, and $50,000 to Johns Hopkins University for targeting SHP2 as a therapeutic strategy in fusion-negative rhabdomyosarcoma. Immune-based approaches are another clear focus. The foundation awarded $125,000 to the University of Texas MD Anderson Cancer Center for combining a dendritic cell vaccine with checkpoint blockade for osteosarcoma therapy, and $75,000 to Baylor College of Medicine for off-the-shelf combination cancer immunotherapy with oncolytic adeno-immunotherapy and CAR NK cell therapy for pediatric sarcoma. It also supports diagnostic and response-monitoring research. Dana Farber received $105,000 for prospective validation of a prognostic liquid biopsy approach for pediatric Ewing sarcoma, while the University of Florida was funded for investigating the immune response to RNA-lipid nanoparticle vaccines in a clinical trial for canines with osteosarcoma.
How Pediatric Cancer Research Foundation Gives
Financial Snapshot
Annual Giving
$1.5M
Total Assets
$3.7M
Total Revenue
$4.2M
Total Expenses
$3.7M
Typical Grant Size
Most grants fall between $50K and $75K, with a median of $50K.
25th Percentile
$50K
Median
$50K
75th Percentile
$75K
Geographic Reach
National15 states funded
Funding intensity
LowHigh
Headquarters
Leadership
DANIELLE FRAGALLA
Unlock Deep Analysis
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeSee Similar Funders
Free Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeExplore related grant guides
Want a Personalized Pitch for Pediatric Cancer Research Foundation?
Sign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
Free plan available
No contracts
Cancel anytime